Artemisinin Market

Table Of Content

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Artemisinin Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Artemisinin Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Artemisinin Market, By Source
1. Introduction
  1. Market Size and Forecast, By Source
2. Plant-Based Artemisinin
  1. Market Size and Forecast, By Region
3. Semi-Synthetic Artemisinin
  1. Market Size and Forecast, By Region
Artemisinin Market, By Applications
1. Introduction
  1. Market Size and Forecast, By Applications
2. Antimalarial Treatments
  1. Market Size and Forecast, By Region
3. Anticancer Treatments
  1. Market Size and Forecast, By Region
4. Antiviral Treatments
  1. Market Size and Forecast, By Region
Artemisinin Market, By End-User
1. Introduction
  1. Market Size and Forecast, By End-User
2. Pharmaceutical Sector
  1. Market Size and Forecast, By Region
3. Research Institutions
  1. Market Size and Forecast, By Region
4. Contract Manufacturing Organizations (CMOs)
  1. Market Size and Forecast, By Region
5. Others
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  2. U.S.
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  2. U.K.
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  2. China
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  3. Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  2. UAE
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  2. Brazil
    1. By Source
      1. Plant-Based Artemisinin
      2. Semi-Synthetic Artemisinin
    2. By Applications
      1. Antimalarial Treatments
      2. Anticancer Treatments
      3. Antiviral Treatments
    3. By End-User
      1. Pharmaceutical Sector
      2. Research Institutions
      3. Contract Manufacturing Organizations (CMOs)
      4. Others
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2024
1. Introduction
2. Artemisinin Market Share Analysis, 2024 (%)
  1. Market Share Analysis, 2024
  2. Competition Ranking, 2024
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Sanofi
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. KPC Pharmaceuticals
3. Guilin Pharmaceuticals
4. Holley Pharmaceuticals
5. Beepz, Bionexx
6. Ipca Laboratories
7. Novanat Bioresource
8. Others

	


A PHP Error was encountered

Severity: Warning
Message:  Undefined array key "list_tbl_fig"
Filename: reports/toc.php
Line Number: 79


	Backtrace:
	
		
	
		
	
		
			
			File: /var/www/html/application/views/frontend/reports/toc.php

			Line: 79

			Function: _error_handler			

		
	
		
	
		
	
		
			
			File: /var/www/html/application/controllers/Web.php

			Line: 215

			Function: view			

		
	
		
	
		
			
			File: /var/www/html/index.php

			Line: 316

			Function: require_once

Check Discount

Get Free Sample

Buy Now

Key Topics Covered

Market Factors (Including Drivers and Restraint)
Market Trends
Market Estimates and Forcasts
Competitive Analysis
Future Market Opportunities

Global Artemisinin Market Size, Share & Trends Analysis Report By Source (Plant-Based Artemisinin, Semi-Synthetic Artemisinin), By Applications(Antimalarial Treatments, Anticancer Treatments, Antivira. . . . .

Table Of Content

A PHP Error was encountered